Skip to content

MAPRT

Active
Private limited companyfounded 2024active for 2 yearsPaul Devignestraat 70, 1030 Schaarbeek, Belgium11 active companies are registered at this addressKBO/BCE: BE 1004.288.906
Summary

MAPRT has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €96,042 and a net result of €54,059. Its solvency ranks better than 79% of 20,643 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
≈ €150,000turnover 2025, estimated
Equity
€96,042
Profit
€54,059
Turnover estimated from the gross margin
Financial health
98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts 16 days early
Why 98lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 7.68, cash €82,250Equity €96,042 (87.0% of total assets)Size: total assets €110,411Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 85% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency 100=
equity 87.0% of total assets
Liquidity 98+5
short-term debt 13.0% · cash 74.5%
Profitability 100=
return on assets 49.0%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,138 companies, NACE 86, micro)
Last 24 months 02-2025: 0.3% 03-2025: 0.3%● unchanged vs 02-2025 04-2025: 0.3%● unchanged vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025 06-2025: 0.4%▲ +0.1 percentage points vs 05-2025highest value 07-2025: 0.4%● unchanged vs 06-2025highest value 08-2025: < 0.1%▼ -0.4 percentage points vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value
Credit of up to €9,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity ample (current ratio 7.68, compared with 4.72 in 2024, above the usual 1.5; short-term debt: 13% and cash: 74.5% of total assets), and 13% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 87% on liquidity, 80% on profitability and 92% on growth.

The bankruptcy probability was computed on 28-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 7.68, cash €82,250
NBB · annual accounts
lowers risk · Equity €96,042 (87.0% of total assets)
NBB · annual accounts
lowers risk · Size: total assets €110,411
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Young company
Founded in 2024, 2 years ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 years
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 15-07-2026, 16 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
16 days early
2024
6 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 11 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
29-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2024.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Annual accounts filedfinancial year 2024 · micro…
  3. IncorporationAppointment: PERROT Marie Catherine Bernadette…

Financials · financial year 2025, micro format

Turnover
≈ €150,000
Estimated: probably between €110,000 and €190,000
Total assets
€110,411▲ 104%
2024 · €54,254
Net result
€54,059▲ 28.5%
2024 · €42,075
Working capital
€95,916▲ 125%
2024 · €42,574
Trend over the years

2024 to 2025, 2 financial years

The operating result rises in 2025; 2025 is 28% above 2024.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€67,414 2025 Net result€54,059 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line20242025
Operating result€52,711-€67,414▲ 27.9%
Net result€42,075within the sector's middle half-€54,059within the sector's middle half▲ 28.5%
Equity€42,816below the sector's middle half-€96,042within the sector's middle half▲ 124%
Total assets€54,254below the sector's middle half-€110,411below the sector's middle half▲ 104%
Debt€11,437-€14,369▲ 25.6%
Working capital€42,574within the sector's middle half-€95,916within the sector's middle half▲ 125%
Solvency78.9%within the sector's middle half-87.0%above the sector's middle half▲ 8.1pp
Current ratio4.72within the sector's middle half-7.68above the sector's middle half▲ 2.95
Return on assets (ROA)77.6%above the sector's middle half-49.0%above the sector's middle half▼ 28.6pp
above within below the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the micro format does not require them. The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €110,411
Fixed assets €126 ▼ 48.1%
Current assets €110,285 ▲ 104%
Equity and liabilities €110,411
Equity €96,042 ▲ 124%
Debt €14,369 ▲ 25.6%
Debt's share of the balance-sheet total falls from 21.1% to 13.0%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€67,531▲
2024 · €55,898
Cash flow
€54,176▲
2024 · €45,262
Debt to equity
0.15▼
2024 · 0.27
ROE
56.3%▼
2024 · 98.3%
Interest coverage
over 100
2024 · over 100
Debt ≤ 1 year
€14,369▲
2024 · €11,437
Income taxes
€13,632▲
2024 · €10,578
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 39,278 companies that looked in July 2024 the way this one looks now, 1.8% went bankrupt within 24 months and 95.9% are still going.

  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
1.8% went bankrupt
2.3% stopped otherwise
95.9% still going

For this company itself Checked computes a lower bankruptcy probability: < 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 39,278 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 33 lines
Balance sheet Code20242025
Assets
Total assets20/58€54,254€110,411▲
Fixed assets21/28€243€126▼
Tangible fixed assets22/27€243€126▼
Furniture and vehicles24€243€126▼
Current assets29/58€54,011€110,285▲
Current investments50/53€4,000€28,000▲
Cash at bank and in hand54/58€50,011€82,250▲
Deferred charges and accrued income490/1-€35
Equity and liabilities
Total equity and liabilities10/49€54,254€110,411▲
Equity10/15€42,816€96,042▲
Contributions10/11€1,600€1,600=
Profit (loss) carried forward14€41,216€94,442▲
Amounts payable17/49€11,437€14,369▲
Amounts payable within one year42/48€11,437€14,369▲
Taxes, remuneration and social security45€10,836€13,536▲
Taxes450/3€10,836€13,536▲
Other amounts payable47/48€601€833▲
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3,187€117▼
Other operating charges640/8€106€66▼
Gross operating margin9900€56,004€67,596▲
Operating profit (loss)9901€52,711€67,414▲
Financial income75/76B-€322
Recurring financial income75-€322
Financial charges65/66B€58€45▼
Recurring financial charges65€58€45▼
Profit (loss) for the period before taxes9903€52,654€67,691▲
Income taxes67/77€10,578€13,632▲
Profit (loss) for the period9904€42,075€54,059▲
Profit (loss) for the period to be appropriated9905€42,075€54,059▲
Appropriation of the result
Profit (loss) to be appropriated9906€42,075€95,275▲
Profit (loss) brought forward from the previous period14P-€41,216
Profit to be distributed694/7€859€833▼
Return on contributions (dividend)694€859€833▼

The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3,187€117▼ 96.3%
Other operating charges640/8€106€66▼ 37.7%
Gross operating margin9900€56,004€67,596▲ 20.7%
Operating profit (loss)9901€52,711€67,414▲ 27.9%
Financial income75/76B-€322-
Recurring financial income75-€322-
Financial charges65/66B€58€45▼ 21.8%
Recurring financial charges65€58€45▼ 21.8%
Profit (loss) for the period before taxes9903€52,654€67,691▲ 28.6%
Income taxes67/77€10,578€13,632▲ 28.9%
Profit (loss) for the period9904€42,075€54,059▲ 28.5%
Profit (loss) for the period to be appropriated9905€42,075€54,059▲ 28.5%
Line20242025Change
Assets
Total assets20/58€54,254€110,411▲ 104%
Fixed assets21/28€243€126▼ 48.1%
Tangible fixed assets22/27€243€126▼ 48.1%
Furniture and vehicles24€243€126▼ 48.1%
Current assets29/58€54,011€110,285▲ 104%
Current investments50/53€4,000€28,000▲ 600%
Cash at bank and in hand54/58€50,011€82,250▲ 64.5%
Deferred charges and accrued income490/1-€35-
Equity and liabilities
Total equity and liabilities10/49€54,254€110,411▲ 104%
Equity10/15€42,816€96,042▲ 124%
Contributions10/11€1,600€1,600=
Profit (loss) carried forward14€41,216€94,442▲ 129%
Amounts payable17/49€11,437€14,369▲ 25.6%
Amounts payable within one year42/48€11,437€14,369▲ 25.6%
Taxes, remuneration and social security45€10,836€13,536▲ 24.9%
Taxes450/3€10,836€13,536▲ 24.9%
Other amounts payable47/48€601€833▲ 38.5%
Line20242025Change
Profit (loss) for the period9904€42,075€54,059▲ 28.5%
+ Depreciation and write-downs630€3,187€117▼ 96.3%
Operating cash flow (approximation)€45,262€54,176▲ 19.7%
Investment in fixed assets (approximation)-€0-
Change in cash-€32,239-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (2)
Financial year Type Filed Reference
31-12-2025 micro format 15-07-2026 2026-00295527
31-12-2024 micro format 25-07-2025 2025-00310984

Similar companies · same sector, comparable size

Of the 16,579 active companies whose main activity is specialist medical practice (NACE 86220), figures are known for 8,122. 6,342 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
1 director, no change since 2024
PERROT Marie Catherine Bernadette Vincent
Director (not named in the articles) · since 09-01-2024
Current
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ. See the directors and other office holders in the KBO →

Mandate history

1 person since 2024, 1 in office
Show
  • Board
Mandates per person, with start and end dates
Name Functions and periods
PERROT Marie Catherine Bernadette Vincent
  • Director (not named in the articles), from 09-01-2024 to date
See the board, name and registered office on a given date →

Owners and capital

Capital and shareholders

Shareholders according to the deeds
At incorporation act of 09-01-2024 ↗

The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years
  1. 09-01-2024 Incorporation · 100 shares

Group and network

Connections & network

1 current director
Depth

The network starts from this company’s directors. Other companies they run appear here as nodes.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

History

On 5 January 2024, MAPRT was incorporated as a private limited company by one natural person.12 PERROT Marie Catherine Bernadette Vincent has served as director of the company since 2024.2 The company has filed 2 sets of annual accounts, the latest for financial year 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 09-01-2024
  3. 3National Bank, annual accounts 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
15-07
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
25-07
NBB filing Annual accounts filed
financial year 2024 · micro format
2024
09-01
Gazette deed Incorporation
Appointment: PERROT Marie Catherine Bernadette Vincent (director) · Founder · Capital7 facts ▸
  • Incorporation, 04-01-2024
  • Founder, PERROT Marie Catherine Bernadette Vincent
  • Capital
  • Registered office clause, “1030 Schaerbeek, rue Paul Devigne 70, boîte 17” (deed in French)
  • Board rule, 1
  • Director appointment, PERROT Marie Catherine Bernadette Vincent (director (not named in the articles))
  • Pre-incorporation commitments, “takeover, Tous les engagements ainsi que les obligations qui en résultent, et toutes les activités entreprises par l’un ou l’autre des comparants au nom et pour…” (deed in French)
Gazette deedNBB filing
1 of 1 deed read

Register details

Identification
Legal formPrivate limited company
Founded05-01-2024
Financial year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID 0208:1004288906
Registered 06-01-2026

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 29 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Schaarbeek · 1 establishment unit since 2024
registered office establishment The establishment unit on the map
Ground area
4,273 m²
Building footprint
463 m²
Building volume
11,503 m³
Parcel 21904B0460/00M006, Brussels · tallest building 28.6 m. Linked by address, not a title deed.
11 companies at this address See who is registered here
1 establishment unit
MAPRT
Paul Devignestraat 70, 1030 SchaarbeekSpecialist medical practice
since 2024unit no. 2.354.553.551
1 parcel
Brussels 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
21904B0460/00M006 Brussels 4,273 m² 1 · 463 m² 28.6 m · 9
How the parcels are linked
Good to know
The parcel matches the address exactly.

Articles of association

What the company does

PurposeThe activities the company may carry out under its articles.
“L’exercice de la médecine et plus particulièrement, sans être exhaustif, la médecine interne, pneumologie; Toute transaction mobilière et…” (deed in French)
8 activities (deed in French)
  1. L’exercice de la médecine et plus particulièrement, sans être exhaustif, la médecine interne, pneumologie
  2. Toute transaction mobilière et immobilière concernant les locaux médicaux
  3. L'achat du matériel médical et non médical
  4. L'engagement du personnel administratif, soignant, pratiquant ou appelé à pratiquer dans la société
  5. Tous travaux de recherche scientifique, en ce compris la rédaction, l’édition et la publication d’ouvrages et d’articles à caractère scientifique rédigés par elle
  6. L’organisation et la participation à des conférences, colloques, séminaires, cours, congrès, recyclages et stages de formation
  7. La constitution, au départ de ses moyens propres ou éventuellement par le recours à des emprunts, la gestion et la valorisation d'un patrimoine immobilier, notamment par l'achat, la vente, la location, la mise à disposition, la concession de droits réels, la construction, la transformation et la rénovation, le tout au sens le plus large
  8. Tous actes et toutes opérations généralement quelconques de nature financière, mobilière ou immobilière, en ce compris donner des garanties (à l’exception de ses propres actions sociales) et hypothéquer, se rapportant directement ou indirectement à la réalisation de son objet, sans en modifier la vocation médicale

The full purpose is in the deed

DurationHow long the company exists; usually unlimited, so until it is dissolved.
Unlimited
Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
One provision in the deed

deed of 09-01-2024

Who represents it, and how

Board ruleHow the board is made up, meets and takes decisions.
4 provisions in the deed

deed of 09-01-2024

Capital, shares and profit

Kind of sharesWhich classes of shares exist and what rights each class carries.
“Le registre des actions peut être tenu en la forme électronique, nominatives” (deed in French)
“La société ne reconnait, quant à l’exercice des droits accordés aux actionnaires, qu’un seul propriétaire pour chaque titre, Les titres sont…” (deed in French)
Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
One provision in the deed
Share issue ruleHow and by whom new shares can be issued.
“Libérées à leur émission, En cas d’actionnaire unique-administrateur, ce dernier détermine librement, au fur et à mesure des besoins de la…” (deed in French)
“Courrier électronique, ou, pour les personnes dont elle ne dispose pas d’une adresse électronique, par courrier ordinaire, à envoyer le même…” (deed in French)

deed of 09-01-2024

Meetings and financial year

Meeting noticeHow and how far ahead shareholders are invited to a meeting; by law at least fifteen days.
One provision in the deed
Meeting accessWho may attend the meeting and what is needed to be admitted.
One provision in the deed
Meeting procedureHow the meeting runs, from opening to minutes.
3 provisions in the deed
Voting ruleWhich majority the meeting decides by, for example a simple or a special majority.
One provision in the deed

deed of 09-01-2024

Oversight and winding up

Statutory auditorA statutory auditor is a registered auditor who checks the accounts; small companies need not have one. According to the deed, the legal criteria do not require one here.
No statutory auditor
Dissolution ruleWhen and by whom the company can be dissolved.
“La société peut être dissoute en tout temps, par décision de l'assemblée générale délibérant dans les formes prévues pour les modifications…” (deed in French)
Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
“En cas de dissolution de la société, pour quelque cause et à quelque moment que ce soit, la liquidation s'opère par le ou les…” (deed in French)

deed of 09-01-2024

Other provisionsOther rules from the articles that fall under none of the themes above.

Other provision: “Toute assemblée ne peut délibérer que sur les propositions figurant à l’ordre du jour, sauf si toutes les personnes à convoquer sont…” (deed in French)
Other provision: “Sauf dans les cas prévus par la loi ou les présents statuts ou sauf si le Code de Déontologie prévoit une majorité différente ou l'unanimité…” (deed in French)
Other provision: “Toute assemblée générale, ordinaire ou extraordinaire, peut être prorogée, séance tenante, à trois semaines au plus par l’organe…” (deed in French)
Other provision: “Le bénéfice annuel net recevra l’affectation que lui donnera l'assemblée générale, statuant sur proposition de l’organe d’administration…” (deed in French)
Other provision: “Les actionnaires s'engagent à respecter les règles du Code de Déontologie médicale. L'exercice de la médecine dans la société devra…” (deed in French)
Other provision: “Pour tout litige entre la société, ses actionnaires, gérants, commissaires et liquidateurs relatifs aux affaires de la société et à…” (deed in French)
Other provision: “Les dispositions du Code des sociétés et des associations auxquelles il ne serait pas licitement dérogé sont réputées inscrites dans les…” (deed in French)
3 more provisions in the deed, see the deed of 09-01-2024

deed of 09-01-2024